Company / Operating Cash Flow
Nuvation Bio Inc. Operating Cash Flow History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$173.4M
FY2025
5-year range
-$173.4M / -$68.0M
FY2021-FY2025
Trend
-33.0%
vs FY2024
Sector context
#162 of 216
Health Care
What the data says
Nuvation Bio Inc.'s operating cash flow of -$173M is lower than 75% of companies in the Health Care sector (FY2025). Declined from -$68M to -$173M over the past 2 years.
Based on SEC 10-K filings.
-$173M in FY2025.
Declined from -$68M to -$173M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 216This company -$173.4M Sector average $658.7M
▼
-126.3% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 33.0% year-over-year.
- Ranks #162 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$173.4M | -33.0% |
| FY2024 | -$130.4M | -91.8% |
| FY2023 | -$68.0M | +29.2% |
| FY2022 | -$96.1M | -40.9% |
| FY2021 | -$68.2M | -86.7% |
| FY2020 | -$36.5M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026